A detailed history of Chesapeake Wealth Management transactions in Johnson & Johnson stock. As of the latest transaction made, Chesapeake Wealth Management holds 8,460 shares of JNJ stock, worth $1.23 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
8,460
Previous 8,370 1.08%
Holding current value
$1.23 Million
Previous $1.22 Million 12.1%
% of portfolio
0.47%
Previous 0.45%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$145.48 - $167.38 $13,093 - $15,064
90 Added 1.08%
8,460 $1.37 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $2,021 - $2,208
-14 Reduced 0.17%
8,370 $1.22 Million
Q1 2024

May 07, 2024

SELL
$155.22 - $162.74 $39,115 - $41,010
-252 Reduced 2.92%
8,384 $1.33 Million
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $31,012 - $33,841
-213 Reduced 2.41%
8,636 $1.35 Million
Q3 2023

Nov 16, 2023

SELL
$155.75 - $174.48 $54,045 - $60,544
-347 Reduced 3.77%
8,849 $1.38 Million
Q2 2023

Aug 01, 2023

BUY
$154.35 - $166.11 $9,261 - $9,966
60 Added 0.66%
9,196 $1.52 Million
Q1 2023

Apr 25, 2023

SELL
$151.05 - $180.26 $37,158 - $44,343
-246 Reduced 2.62%
9,136 $1.42 Million
Q4 2022

Feb 23, 2023

SELL
$160.2 - $179.79 $28,034 - $31,463
-175 Reduced 1.83%
9,382 $1.66 Million
Q3 2022

Oct 28, 2022

SELL
$161.33 - $179.52 $27,103 - $30,159
-168 Reduced 1.73%
9,557 $1.56 Million
Q2 2022

Jul 21, 2022

SELL
$168.19 - $186.01 $138,252 - $152,900
-822 Reduced 7.79%
9,725 $1.73 Million
Q1 2022

Apr 19, 2022

BUY
$158.14 - $179.59 $44,911 - $51,003
284 Added 2.77%
10,547 $1.87 Million
Q4 2021

Feb 03, 2022

SELL
$155.93 - $173.01 $87,632 - $97,231
-562 Reduced 5.19%
10,263 $1.76 Million
Q3 2021

Oct 26, 2021

SELL
$161.5 - $179.47 $230,783 - $256,462
-1,429 Reduced 11.66%
10,825 $1.75 Million
Q2 2021

Jul 29, 2021

SELL
$159.48 - $171.07 $98,080 - $105,208
-615 Reduced 4.78%
12,254 $2.02 Million
Q1 2021

Apr 26, 2021

SELL
$153.07 - $170.48 $74,085 - $82,512
-484 Reduced 3.62%
12,869 $2.12 Million
Q4 2020

Feb 05, 2021

SELL
$137.11 - $157.38 $49,908 - $57,286
-364 Reduced 2.65%
13,353 $2.1 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $30,602 - $33,534
-218 Reduced 1.56%
13,717 $2.04 Million
Q2 2020

Aug 11, 2020

BUY
$128.81 - $155.51 $41,219 - $49,763
320 Added 2.35%
13,935 $1.96 Million
Q1 2020

Apr 29, 2020

SELL
$111.14 - $153.99 $46,901 - $64,983
-422 Reduced 3.01%
13,615 $1.79 Million
Q4 2019

Jan 29, 2020

SELL
$127.5 - $146.44 $163,200 - $187,443
-1,280 Reduced 8.36%
14,037 $2.05 Million
Q3 2019

Oct 25, 2019

SELL
$126.95 - $142.14 $37,577 - $42,073
-296 Reduced 1.9%
15,317 $1.98 Million
Q2 2019

Aug 01, 2019

SELL
$131.15 - $144.24 $97,575 - $107,314
-744 Reduced 4.55%
15,613 $2.18 Million
Q1 2019

Apr 17, 2019

SELL
$125.72 - $139.79 $37,087 - $41,238
-295 Reduced 1.77%
16,357 $2.29 Million
Q4 2018

Feb 06, 2019

SELL
$122.84 - $147.84 $26,410 - $31,785
-215 Reduced 1.27%
16,652 $2.15 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $74,285 - $87,299
-611 Reduced 3.5%
16,867 $2.33 Million
Q2 2018

Aug 07, 2018

SELL
$119.4 - $131.76 $281,903 - $311,085
-2,361 Reduced 11.9%
17,478 $2.12 Million
Q1 2018

Jun 04, 2018

BUY
$125.1 - $148.14 $2.48 Million - $2.94 Million
19,839 New
19,839 $2.54 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Chesapeake Wealth Management Portfolio

Follow Chesapeake Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Wealth Management with notifications on news.